LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • May 10th, 2021 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • New York
THIS LICENSE AND SUPPLY AGREEMENT (“Agreement”) is made effective as of the 21st day of March, 2021 (the “Effective Date”), by and between Immedica Pharma AB, a corporation organized and existing under the laws of Sweden with offices at Norrtullsgatan 15, SE 113 29 Stockholm, Sweden (“IMMEDICA”) and Aeglea BioTherapeutics, Inc., a corporation organized and existing under the laws of Delaware with offices at 805 Las Cimas Parkway, Suite 100, Austin, Texas, U.S.A. (“LICENSOR”). IMMEDICA and LICENSOR may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties”.
